[1]朱紫墨,杨延麟,汪利合.基于CiteSpace的仙灵骨葆临床研究可视化分析[J].中医正骨,2024,36(05):39-44.
　ZHU Zimo,YANG Yanlin,WANG Lihe.A CiteSpace-based visualization analysis of clinical research on Xianling Gubao(仙灵骨葆)[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2024,36(05):39-44.
点击复制

基于CiteSpace的仙灵骨葆临床研究可视化分析()
分享到：

《中医正骨》[ISSN:1001-6015/CN:41-1162/R]

卷:
第36卷
期数:
2024年05期
页码:
39-44
栏目:
文献研究
出版日期:
2024-05-20

文章信息/Info

Title:
A CiteSpace-based visualization analysis of clinical research on Xianling Gubao(仙灵骨葆)
作者:
朱紫墨1; 杨延麟2; 汪利合3
1.河南中医药大学骨伤学院,河南 郑州 450002; 2.河南理工大学,河南 焦作 454000; 3.河南中医药大学第一附属医院,河南 郑州 450000
Author(s):
ZHU Zimo1; YANG Yanlin2; WANG Lihe3
1.College of Orthopaedics and Traumatology of Henan University of Chinese Medicine,Zhengzhou 450002,Henan,China 2.Henan Polytechnic University,Jiaozuo 454000,Henan,China 3.The First Affiliated Hospital of Henan University of Chinese Medicine,Zhengzhou 450000,Henan,China
关键词:
仙灵骨葆胶囊;  数据可视化;  聚类分析
Keywords:
Xian Ling Gu Bao Jiao Nang;  data visualization;  cluster analysis
摘要:
目的:通过CiteSpace可视化分析探究仙灵骨葆的临床研究现状与发展趋势。方法:应用计算机在中国知网中检索关于仙灵骨葆的临床研究文献,检索年限为1991—2023年。根据文献纳入标准和排除标准筛选文献,将引文数据导入CiteSpace软件,对年发文量、作者、机构、关键词等进行可视化分析。结果:①一般结果。检索获得文献848篇,最终纳入文献624篇,发表在233种期刊上,涉及作者1692位、机构776家。②年发文量。1999—2005年,年发文量均在10篇以下,且波动不大; 2006—2008年,年发文量呈快速上升趋势; 2009—2013年,年发文量维持在20～30篇,呈小幅波动趋势; 2014—2017年,年发文量逐步增加,并在2017年达到峰值; 2018—2023年,年发文量呈波动性下降趋势。③作者。发文量较大的作者合作网络分别是以史晓林为核心的合作网络和包括史历、侯钦午、马俊岭等的合作网络。④机构。发文量位于前5的机构依次为浙江省丽水市中心医院、广州中医药大学第一附属医院、上海市浦东新区北蔡社区卫生服务中心、浙江中医药大学第二附属医院、中国中医科学院中医临床基础医学研究所。⑤关键词。共现网络分析结果显示,突出节点有仙灵骨葆、骨质疏松、骨密度、临床观察、临床疗效等; 频次分析结果显示,仙灵骨葆、骨质疏松、骨密度、临床观察出现频次较高; 聚类分析结果显示,仙灵骨葆、骨质疏松、骨折、骨密度聚类规模较大; 突现分析结果显示,2005年前的突现词为临床观察、中药治疗、骨复活汤,2006—2008年的突现词为临床研究、膝关节、骨关节炎等,2009—2017年的突现词为玻璃酸钠、骨折愈合、钙尔奇D等,2018年后的突现词为骨代谢、生活质量、甲氨蝶呤等。结论:仙灵骨葆的临床研究整体上处于稳定发展中,出现了阶段性的上升和下降; 研究团队较少,作者较为分散,团队之间合作不紧密; 研究机构分布广泛,机构之间合作不紧密; 仙灵骨葆治疗骨质疏松的关注度较高; 探究仙灵骨葆影响骨代谢的作用机制可能是下一阶段的研究方向。
Abstract:
Objective:To explore the clinical research status and trends of Xianling Gubao(仙灵骨葆,XLGB)through a CiteSpace-based visual analysis.Methods:The clinical research articles about XLGB included from 1991 to 2023 were retrieved from China National Knowledge Infrastructure through computer.The articles were screened according to the inclusion and exclusion criteria,and then the data from the included articles were imported into the CiteSpace software for visually analyzing the annual number of publications,authors,institutions,and keywords.Results:①Eight hundred and forty-eight articles were searched out.After screening,624 ones were included in the final analysis,involving 233 journals,1692 authors,and 776 institutions.②The annual number of publications was below 10 with slight fluctuations from 1999 to 2005,surged from 2006 to 2008,remained at 20-30 with slight fluctuations from 2009 to 2013,gradually increased from 2014 to 2017 and peaked in 2017,and declined with fluctuations from 2018 to 2023.③The author collaboration networks with a large number of publications were that centered around SHI Xiaolin and that including SHI Li,HOU Qinwu,and MA Junling.④The top 5 institutions with the largest number of publications were Lishui Central Hospital of Zhejiang Province,The First Affiliated Hospital of Guangzhou University of Chinese Medicine,Beicai Community Health Service Center in Pudong New Area of Shanghai,The Second Affiliated Hospital of Zhejiang Chinese Medical University,and Institute of Basic Research in Clinical Medicine,China Academy of Chinese Medical Sciences inturn.⑤The result of keyword co-occurrence network(KCN)analysis showed that the salient nodes included XLGB,osteoporosis(OP),bone mineral density(BMD),clinical observation,and clinical efficacy.The result of frequency analysis showed that XLGB,OP,BMD and clinical observation appeared more frequently.The cluster analysis revealed large clusters on XLGB,OP,fractures,and BMD.Furthermore,the keyword burst analysis indicated that the burst keywords were clinical observation,Chinese medicine treatment,and Gufuhuo Tang(骨复活汤)before 2005; clinical research,knee joint,and osteoarthritis during 2006-2008; sodium hyaluronate,fracture healing,and calcium carbonate and vitamin D3 tablets during 2009-2017; and bone metabolism,quality of life,and methotrexate after 2018.Conclusion:The clinical research on XLGB exhibits steady development in general,with phased rises and declines; meanwhile,less research teams are concerned on XLGB,with scattered authors and loose collaboration between teams; besides,the related research institutions are wide-spreading with loose collaboration.XLGB has attracted more attention in treatment of OP,and its mechanism(s)involved in regulating bone metabolism may be a future research orientation.

参考文献/References:

[1] 邢燕,毕宏焱,张倩楠,等.骨质疏松常用中成药介绍[J].中国骨质疏松杂志,2013,19(1):83-85.
[2] 李杰,陈超美.CiteSpace科技文本挖掘及可视化[M].3版.北京:首都经济贸易大学出版社,2022:3.
[3] 王眠龙.仙灵骨葆胶囊治疗骨质疏松症导致腰腿痛的典型病例报告[J].海峡药学,1999,11(S2):92-93.
[4] 胡彩仙,程梅芬.仙灵骨葆胶囊治疗骨质疏松症30例的临床观察[J].中成药,2000,22(3):246-247.
[5] 方向明,王蓬华,杨强.仙灵骨葆治疗老年性骨质疏松症的疗效观察[J].现代康复,2001,5(6):87.
[6] 邵光湘,韩铭,韩琳.仙灵骨葆胶囊治疗酒精性股骨头坏死的临床观察[J].中国中医骨伤科杂志,2006,14(S2):106-108.
[7] 尚玉敏,刘艳艳,李惠萍.仙灵骨葆胶囊治疗绝经后骨质疏松症的临床观察[J].中国中西医结合急救杂志,2007,14(1):55.
[8] 吴鹏强,徐花兰.仙灵骨葆胶囊防治老年性胸腰椎骨质疏松症[J].浙江中西医结合杂志,2007,17(7):429-430.
[9] 吴剑,鲍同柱,鄢飞,等.栀子粉外敷加仙灵骨葆治疗膝骨性关节炎[J].山东中医杂志,2008,27(9):594-595.
[10] 崔书国,赵建,崔喜双.仙灵骨葆配合中药熏洗治疗膝骨性关节炎60例[J].河北中医药学报,2008,23(3):26-27.
[11] 魏书亭.仙灵骨葆胶囊配合阿伦磷酸钠治疗原发性骨质疏松症98例疗效观察[J].亚太传统医药,2013,9(1):173-174.
[12] 赵杨,王广宏.仙灵骨葆联合玻璃酸钠治疗膝关节骨性关节炎的临床观察[J].中医药信息,2011,28(4):86-87.
[13] 邵亚超.仙灵骨葆联合玻璃酸钠治疗膝骨性关节炎46例[J].中国药业,2015,24(4):88.
[14] 陈少初,胡益雄,赖俊成,等.医用臭氧联合仙灵骨葆胶囊治疗膝骨性关节炎40例疗效观察[J].海南医学,2013,24(7):960-963.
[15] 钟芳晓,王武琦.仙灵骨葆胶囊联合医用臭氧对膝骨性关节炎疼痛及膝关节功能影响的分析[J].新中医,2015,47(8):120-122.
[16] 吴中琴.仙灵骨葆胶囊合用钙尔奇D治疗女性绝经后骨质疏松症的疗效观察[J].海峡药学,2010,22(12):159-160.
[17] 冯炎林,陈文钦,吴奋飞.仙灵骨葆、福善美联合钙尔奇D治疗骨质疏松的效果比较[J].海峡药学,2013,25(6):163-164.
[18] 鲍军国,李新春.仙灵骨葆胶囊联合钙尔奇D和阿仑膦酸钠片治疗老年骨质疏松的疗效比较研究[J].辽宁中医杂志,2015,42(4):784-785.
[19] 汪发莲,杨生仁,李舜君,等.仙灵骨葆胶囊联合阿仑膦酸钠对骨质疏松症患者的骨代谢及骨转换指标的影响[J].药物评价研究,2020,43(11):2259-2262.
[20] 吴耀华,吴稀民,付远亮,等.仙灵骨葆胶囊治疗骨质疏松症的疗效及对骨密度、骨代谢的影响[J].北方药学,2022,19(7):65-67.
[21] 潘方瑛,张健儿,郑美暄.仙灵骨葆胶囊联合唑来膦酸盐、钙尔奇D治疗骨质疏松症疗效观察及对骨代谢指标的影响[J].新中医,2022,54(11):138-141.
[22] 郦妙尔,苏进展,宋侠,等.基于定量CT评价仙灵骨葆胶囊治疗骨质疏松的疗效分析[J].中国中医药科技,2023,30(5):884-886.

备注/Memo

备注/Memo:
基金项目:河南省中医药拔尖人才培养项目(豫中医科教〔2018〕35号)
通讯作者:杨延麟 E-mail:yangyanlin@hpu.edu.cn
更新日期/Last Update: 1900-01-01